Echo IQ Ltd (ASX: EIQ) has been one of the fastest-growing stocks on the ASX this year.
Since January, it has risen over 500%. Fortunately for prospective investors, the team at Morgans believes this growth is set to continue.
Image source: Getty Images
Company overview
EchoIQ develops artificial intelligence for the cardiac diagnostics sector and supplies software to the health fund and insurance sectors.
It operates through the Houston WeHave Software and Echo IQ segments.
The Houston WeHave Software segment offers products and services across defence and other sectors.
The Echo IQ segment focuses on developing artificial intelligence software that aids in predicting Aortic Stenosis heart condition.
In 2026, it has risen more than 500% as investors responded to a series of major commercial milestones.
This includes its strategic partnership with Pro Medicus, new US market opportunities, a $110 million capital raising, and expanded access to a large cardiovascular imaging dataset to strengthen its AI-powered diagnostic platform.
The rally has also been fuelled by optimism that these developments could accelerate US commercialisation and establish Echo IQ as a leading player in AI-driven cardiovascular diagnostics.
Morgans upgrades its outlook
Yesterday, the team at Morgans released an updated note on this ASX growth stock.
It said Echo IQ has de-risked the commercial pathway since Morgan's initiation via a $110m placement at $1.45 per share and a new distribution partnership with Pro Medicus.
HF FDA clearance remains the single biggest re-rating catalyst from here, and while timing has slipped slightly from our expected 4Q26 window, we remain confident on approval and expect feedback imminently. We lift our discounted target price to $1.85 (from $1.30), driven by a medium-term acceleration of revenues. Speculative Buy rating retained.
From yesterday's closing price of $1.57, this indicates a further upside of nearly 18%.
Elsewhere, Bell Potter recently tipped further upside for this ASX growth stock.
It has a price target of $1.75 on Echo IQ shares.
The broker said Echo IQ is making good progress by developing new products and securing long-term funding.
The broker warned, however, that the share price could experience volatility in coming months for several reasons:
- Revenue growth is expected to be modest over the next two years.
- The company will continue to spend significant cash.
- The share price will likely move based on announcements of new customer wins.
